Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.7 million.

  • Biodesix's Non Operating Income rose 12.0% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 2328.57%. This contributed to the annual value of -$8.4 million for FY2024, which is 2194.56% up from last year.
  • As of Q3 2025, Biodesix's Non Operating Income stood at -$1.7 million, which was up 12.0% from -$1.7 million recorded in Q2 2025.
  • Biodesix's Non Operating Income's 5-year high stood at $1.6 million during Q3 2021, with a 5-year trough of -$6.4 million in Q4 2022.
  • Its 5-year average for Non Operating Income is -$2.2 million, with a median of -$2.0 million in 2025.
  • As far as peak fluctuations go, Biodesix's Non Operating Income surged by 16053.74% in 2021, and later crashed by 41509.2% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Non Operating Income stood at -$1.6 million in 2021, then plummeted by 302.25% to -$6.4 million in 2022, then soared by 64.81% to -$2.3 million in 2023, then increased by 29.4% to -$1.6 million in 2024, then dropped by 3.93% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q3 2025, -$1.7 million for Q2 2025, and -$2.0 million during Q1 2025.